This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Assessing the Effect of Various Blood Glucose Levels on 18F-FDG Activity in the Brain, Liver, and Blood Pool
- The value of 18F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study
- Restricting carbohydrates to fight head and neck cancer--is this realistic?
- EANM/SNMMI Guideline for 18F-FDG Use in Inflammation and Infection
- Impact of Noninsulin-Dependent Type 2 Diabetes on Carotid Wall 18F-Fluorodeoxyglucose Positron Emission Tomography Uptake
- Diabetes and Vascular 18F-Fluorodeoxyglucose Positron Emission Tomography Uptake: Another Step Toward Understanding Inflammation in Atherosclerosis
- Effects of Administration Route, Dietary Condition, and Blood Glucose Level on Kinetics and Uptake of 18F-FDG in Mice
- Do Hyperglycemia and Diabetes Affect the Incidence of False-Negative 18F-FDG PET/CT Studies in Patients Evaluated for Infection or Inflammation and Cancer? A Comparative Analysis
- Impact of Intravenous Insulin on 18F-FDG PET in Diabetic Cancer Patients
- Role of Modern Imaging Techniques for Diagnosis of Infection in the Era of 18F-Fluorodeoxyglucose Positron Emission Tomography
- 18F-FDG PET and PET/CT in Fever of Unknown Origin
- Impact of Animal Handling on the Results of 18F-FDG PET Studies in Mice
- Glucose-Normalized Standardized Uptake Value from 18F-FDG PET in Classifying Lymphomas
- Use of PET for Monitoring Cancer Therapy and for Predicting Outcome
- Is 18F-3'-Fluoro-3'-Deoxy-L-Thymidine Useful for the Staging and Restaging of Non-Small Cell Lung Cancer?
- 3'-18F-Fluoro-3'-Deoxy-L-Thymidine: A New Tracer for Staging Metastatic Melanoma?
- Methods to Monitor Response to Chemotherapy in Non-Small Cell Lung Cancer with 18F-FDG PET
- Comparison of 11C-Choline and 18F-FDG PET in Primary Diagnosis and Staging of Patients with Thoracic Cancer
- Positron Emission Tomography Using [18F]-Fluorodeoxy-D-Glucose to Predict the Pathologic Response of Breast Cancer to Primary Chemotherapy
- Current role of positron emission tomography in thoracic oncology
- Positron Emission Tomography in Non-Hodgkin's Lymphoma: Assessment of Chemotherapy With Fluorodeoxyglucose